Literature DB >> 15481614

Postsplenectomy recurrence of thrombocytopenia with an accessory spleen.

Jin Hyun Woo1, Sung Hyun Park, Yoon Kyung Park, Chan Bum Choi, Yun Young Choi, Myung Ju Ahn, In Soon Kim.   

Abstract

Autoimmune thrombocytopenic purpura (AITP) is an autoimmune disorder that results from antiplatelet autoantibodies; these autoantibodies cause platelet destruction in the reticluoendothelial system. Oral corticosteroid therapy is the first line treatment. Splenectomy is the major treatment modality after the failure of more conservative medical therapy. Approximately 15% of the patients will relapse either soon after splenectomy or, as is less common, many years later. The presence of an accessory spleen should be sought. We experienced a patient with a known diagnosis of autoimmune thrombocytopenic purpura who had a worsening thrombocytopenia 11 years after splenectomy. This patient was diagnosed with an accessory spleen. Accessory splenectomy was performed with only a transient elevation of the platelets. We report here on this case with a review of the literature.

Entities:  

Mesh:

Year:  2004        PMID: 15481614      PMCID: PMC4531559          DOI: 10.3904/kjim.2004.19.3.199

Source DB:  PubMed          Journal:  Korean J Intern Med        ISSN: 1226-3303            Impact factor:   2.884


  10 in total

1.  Morbidity and mortality in adults with idiopathic thrombocytopenic purpura.

Authors:  J E Portielje; R G Westendorp; H C Kluin-Nelemans; A Brand
Journal:  Blood       Date:  2001-05-01       Impact factor: 22.113

Review 2.  Fifty years of idiopathic thrombocytopenic purpura (ITP): management of refractory itp in adults.

Authors:  Drew Provan; Adrian Newland
Journal:  Br J Haematol       Date:  2002-09       Impact factor: 6.998

3.  Accessory spleen in recurrent chronic immune thrombocytopenic purpura.

Authors:  T Facon; M T Caulier; P Fenaux; I Plantier; X Marchandise; M Ribet; J P Jouet; F Bauters
Journal:  Am J Hematol       Date:  1992-11       Impact factor: 10.047

Review 4.  Therapy for adults with refractory chronic immune thrombocytopenic purpura.

Authors:  R McMillan
Journal:  Ann Intern Med       Date:  1997-02-15       Impact factor: 25.391

Review 5.  Intravenous treatment with gammaglobulin in adults with immune thrombocytopenic purpura: review of the literature.

Authors:  J B Bussel; L C Pham
Journal:  Vox Sang       Date:  1987       Impact factor: 2.144

Review 6.  Chronic idiopathic thrombocytopenic purpura.

Authors:  J N George; M A el-Harake; G E Raskob
Journal:  N Engl J Med       Date:  1994-11-03       Impact factor: 91.245

7.  Accessory spleens: clinical significance with particular reference to the recurrence of idiopathic thrombocytopenic purpura.

Authors:  W J Rudowski
Journal:  World J Surg       Date:  1985-06       Impact factor: 3.352

8.  The incidence of idiopathic thrombocytopenic purpura in adults increases with age.

Authors:  H Frederiksen; K Schmidt
Journal:  Blood       Date:  1999-08-01       Impact factor: 22.113

9.  Mechanisms of thrombocytopenia in chronic autoimmune thrombocytopenic purpura. Evidence of both impaired platelet production and increased platelet clearance.

Authors:  P J Ballem; G M Segal; J R Stratton; T Gernsheimer; J W Adamson; S J Slichter
Journal:  J Clin Invest       Date:  1987-07       Impact factor: 14.808

10.  Long-term observation of 208 adults with chronic idiopathic thrombocytopenic purpura.

Authors:  R Stasi; E Stipa; M Masi; M Cecconi; M T Scimò; F Oliva; A Sciarra; A P Perrotti; G Adomo; S Amadori
Journal:  Am J Med       Date:  1995-05       Impact factor: 4.965

  10 in total
  2 in total

1.  Platelet count evolution as a predictor of outcome after splenectomy for immune thrombocytopenic purpura.

Authors:  Moonhwan Kim; Keun Myoung Park; Woo Young Shin; Yun-Mee Choe; Keon-Young Lee; Seung-Ik Ahn
Journal:  Int J Hematol       Date:  2016-10-27       Impact factor: 2.490

2.  Intrapancreatic accessory spleen: a rare cause of recurrence of immune thrombocytopenic purpura.

Authors:  Francisco García Angarita; Alfonso Sanjuanbenito Dehesa
Journal:  Clin Case Rep       Date:  2016-09-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.